Efficacy and Safety of IBS Digital Behavioral Treatment

NACompletedINTERVENTIONAL
Enrollment

378

Participants

Timeline

Start Date

October 23, 2019

Primary Completion Date

October 28, 2020

Study Completion Date

October 26, 2021

Conditions
Irritable Bowel Syndrome
Interventions
DEVICE

Arm 1 - Active behavioral Treatment Arm (Regulora; Gut-Directed Hypnotherapy Software as a Medical Device - SaMD)

The active treatment consists of 7 unique video/audio recordings administered via a mobile application every other week for 12 weeks (SaMD). Since subjects in both the active and comparator treatment arms receive a behavioral treatment, the subjects are blinded to active treatment.

DEVICE

Arm 2 - Active Comparator behavioral treatment arm (MR-1; Muscle Relaxation, Software as a Medical Device - SaMD)

The comparator treatment consists of an identical treatment platform, scheduling platform, and reminder platform as the Active Treatment Arm, but in place of Gut-Directed Hypnotherapy there is a comparator relaxation treatment administered on an identical schedule: 7 unique video/audio recordings administered via a mobile application every other week for 12 weeks.

Trial Locations (1)

94122

Curebase, San Francisco

All Listed Sponsors
lead

metaMe Health

INDUSTRY

NCT04133519 - Efficacy and Safety of IBS Digital Behavioral Treatment | Biotech Hunter | Biotech Hunter